These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

583 related items for PubMed ID: 17291214

  • 21. Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation.
    Gross TG, Bucuvalas JC, Park JR, Greiner TC, Hinrich SH, Kaufman SS, Langnas AN, McDonald RA, Ryckman FC, Shaw BW, Sudan DL, Lynch JC.
    J Clin Oncol; 2005 Sep 20; 23(27):6481-8. PubMed ID: 16170157
    [Abstract] [Full Text] [Related]

  • 22. Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients.
    Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P.
    Transplantation; 2007 Aug 15; 84(3):387-91. PubMed ID: 17700165
    [Abstract] [Full Text] [Related]

  • 23. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec 15; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 24. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease.
    Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE.
    Mod Pathol; 1996 Jun 15; 9(6):621-30. PubMed ID: 8782198
    [Abstract] [Full Text] [Related]

  • 25. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug 15; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 26. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 27. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 15; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 28. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R.
    Autoimmun Rev; 2007 Dec 15; 7(2):96-101. PubMed ID: 18035317
    [Abstract] [Full Text] [Related]

  • 29. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
    Gulley ML, Swinnen LJ, Plaisance KT, Schnell C, Grogan TM, Schneider BG, Southwest Oncology Group.
    Transplantation; 2003 Sep 27; 76(6):959-64. PubMed ID: 14508361
    [Abstract] [Full Text] [Related]

  • 30. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 31. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines.
    Parker A, Bowles K, Bradley JA, Emery V, Featherstone C, Gupte G, Marcus R, Parameshwar J, Ramsay A, Newstead C, Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society.
    Br J Haematol; 2010 Jun 01; 149(5):675-92. PubMed ID: 20408847
    [Abstract] [Full Text] [Related]

  • 32. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH, Morrison VA.
    Expert Rev Hematol; 2010 Feb 01; 3(1):35-44. PubMed ID: 21082932
    [Abstract] [Full Text] [Related]

  • 33. Post-transplant lymphoproliferative disorder: a review.
    Loren AW, Porter DL, Stadtmauer EA, Tsai DE.
    Bone Marrow Transplant; 2003 Feb 01; 31(3):145-55. PubMed ID: 12621474
    [Abstract] [Full Text] [Related]

  • 34. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug 01; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 35. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J, Danielian S, Ibañez J, Turconi A, Cuarterolo M, Zelazko M, Niesters Hubert GM.
    J Clin Virol; 2004 Sep 01; 31(1):58-65. PubMed ID: 15288615
    [Abstract] [Full Text] [Related]

  • 36. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R.
    Australas Radiol; 2006 Oct 01; 50(5):412-8. PubMed ID: 16981935
    [Abstract] [Full Text] [Related]

  • 37. Timing of Epstein-Barr virus acquisition and the course of posttransplantation lymphoproliferative disorder in children.
    Wu JF, Ho MC, Ni YH, Chen HL, Lu CY, Hsu HY, Lee PH, Chang MH.
    Transplantation; 2009 Mar 15; 87(5):758-62. PubMed ID: 19295323
    [Abstract] [Full Text] [Related]

  • 38. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
    Purighalla R, Shapiro R, Jordan ML, Scantlebury VP, Gritsch HA, Vivas C, Randhawa PS.
    Clin Transplant; 1997 Dec 15; 11(6):574-6. PubMed ID: 9408687
    [Abstract] [Full Text] [Related]

  • 39. Severe cold agglutinin disease caused by recurrent monomorphic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD), clonally related to an EBV-negative plasmacytic hyperplasia in a pediatric multivisceral organ transplant recipient.
    Brunner B, Kropshofer G, Ellemunter H, Brunner A, Mueller T, Margreiter R, Tzankov A.
    Pediatr Transplant; 2007 Aug 15; 11(5):547-51. PubMed ID: 17631026
    [Abstract] [Full Text] [Related]

  • 40. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep 15; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.